Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification
Authors
Keywords
-
Journal
Current Cardiology Reports
Volume 23, Issue 2, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-13
DOI
10.1007/s11886-020-01437-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases
- (2020) Alexandra Butters et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction
- (2020) Peter Marstrand et al. CIRCULATION
- Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
- (2020) Najim Lahrouchi et al. CIRCULATION
- Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing?
- (2020) Francesco Mazzarotto et al. Journal of the American Heart Association
- Risk Stratification in Hypertrophic Cardiomyopathy. Insights from Genetic Analysis and Cardiopulmonary Exercise Testing
- (2020) Damiano Magrì et al. Journal of Clinical Medicine
- Genetic Testing for Diagnosis of Hypertrophic Cardiomyopathy Mimics
- (2020) Sara Hoss et al. Circulation-Genomic and Precision Medicine
- Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients
- (2020) Weijia Wang et al. EUROPACE
- Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
- (2020) Carolyn Y. Ho et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association
- (2020) Kiran Musunuru et al. Circulation-Genomic and Precision Medicine
- Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2020) Iacopo Olivotto et al. LANCET
- Mavacamten Treatment for Obstructive Hypertrophic Cardiomyopathy
- (2019) Stephen B. Heitner et al. ANNALS OF INTERNAL MEDICINE
- Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies
- (2019) Raquel Yotti et al. Annual Review of Genomics and Human Genetics
- Novel Therapies for Prevention and Early Treatment of Cardiomyopathies
- (2019) Giuliana G. Repetti et al. CIRCULATION RESEARCH
- Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
- (2019) Martin S. Maron et al. JAMA Cardiology
- Hypertrophic Cardiomyopathy–Related Sudden Cardiac Death in Young People in Ontario
- (2019) Adaya Weissler-Snir et al. CIRCULATION
- Hypertrophic Cardiomyopathy: An Overview of Genetics and Management
- (2019) Polakit Teekakirikul et al. Biomolecules
- Development of and Progression of Overt Heart Failure in Nonobstructive Hypertrophic Cardiomyopathy
- (2018) Yasmine L. Hiemstra et al. AMERICAN JOURNAL OF CARDIOLOGY
- Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy
- (2018) Hubert Cochet et al. Archives of Cardiovascular Diseases
- Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
- (2018) Ray E. Hershberger et al. GENETICS IN MEDICINE
- Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel
- (2018) Melissa A Kelly et al. GENETICS IN MEDICINE
- Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
- (2018) Ray E. Hershberger et al. JOURNAL OF CARDIAC FAILURE
- Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy
- (2018) Richard D. Bagnall et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gene therapy strategies in the treatment of hypertrophic cardiomyopathy
- (2018) Maksymilian Prondzynski et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin
- (2018) John A. Rohde et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy
- (2018) Amanda C. Garfinkel et al. Heart Failure Clinics
- Genetic Testing for Cardiomyopathies in Clinical Practice
- (2018) Jodie Ingles et al. Heart Failure Clinics
- Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy
- (2018) Seung-Pyo Lee et al. Circulation-Heart Failure
- Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers
- (2018) Robert L. Anderson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
- (2018) Carolyn Y. Ho et al. CIRCULATION
- Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup
- (2017) Carol Ko et al. GENETICS IN MEDICINE
- Correction of a pathogenic gene mutation in human embryos
- (2017) Hong Ma et al. NATURE
- Prevalence of Rare Genetic Variations and Their Implications in NGS-data Interpretation
- (2017) Yangrae Cho et al. Scientific Reports
- Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation SequencingCLINICAL PERSPECTIVE
- (2017) Charlotte Burns et al. Circulation-Cardiovascular Genetics
- Nonfamilial Hypertrophic CardiomyopathyCLINICAL PERSPECTIVE
- (2017) Jodie Ingles et al. Circulation-Cardiovascular Genetics
- Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes
- (2017) Lorenzo Alamo et al. eLife
- Predictors of atrial fibrillation in hypertrophic cardiomyopathy
- (2016) Oliver P Guttmann et al. HEART
- Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
- (2016) Barry J. Maron et al. HEART RHYTHM
- A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice
- (2016) E. M. Green et al. SCIENCE
- How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality
- (2016) Barry J. Maron et al. JAMA Cardiology
- Predictors of Future Atrial Fibrillation Development in Patients with Hypertrophic Cardiomyopathy: A Prospective Follow-Up Study
- (2015) Kamil Tuluce et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
- (2015) Christopher Semsarian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
- (2014) EUROPEAN HEART JOURNAL
- A straightforward guide to the sarcomeric basis of cardiomyopathies
- (2014) Luís R Lopes et al. HEART
- Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment
- (2014) Brendan N. Putko et al. HEART FAILURE REVIEWS
- Global epidemiology of atrial fibrillation
- (2014) Faisal Rahman et al. Nature Reviews Cardiology
- Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice
- (2014) Giulia Mearini et al. Nature Communications
- Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
- (2013) Susan Colilla et al. AMERICAN JOURNAL OF CARDIOLOGY
- Rescue of cardiomyopathy through U7snRNA-mediated exon skipping inMybpc3-targeted knock-in mice
- (2013) Christina Gedicke-Hornung et al. EMBO Molecular Medicine
- A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)
- (2013) C. O'Mahony et al. EUROPEAN HEART JOURNAL
- Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy
- (2013) Jodie Ingles et al. GENETICS IN MEDICINE
- Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death
- (2013) Connie R Bezzina et al. NATURE GENETICS
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary
- (2011) et al. CIRCULATION
- Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey
- (2011) P. Elliott et al. HEART
- Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women
- (2010) Ole Havndrup et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sarcomere Control Mechanisms and the Dynamics of the Cardiac Cycle
- (2010) R. John Solaro JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Clinical Outcome and Phenotypic Expression in LAMP2 Cardiomyopathy
- (2009) Barry J. Maron JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Significance of Left Atrial Volume Dilatation in Patients with Hypertrophic Cardiomyopathy
- (2009) Maria-Angela Losi et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started